Quantum Genomics Valuation
| ALQGC Stock | EUR 0.12 0.01 7.69% |
Quantum Genomics seems to be overvalued based on Macroaxis valuation methodology. Our model determines the value of Quantum Genomics from analyzing the company fundamentals such as Shares Owned By Insiders of 9.18 %, return on equity of -1.23, and Current Valuation of (11.33 M) as well as examining its technical indicators and probability of bankruptcy. In general, most investors support buying undervalued entities and selling overvalued entities since, at some point, asset prices and their ongoing real values will merge together.
Overvalued
Today
Please note that Quantum Genomics' price fluctuation is out of control at this time. Calculation of the real value of Quantum Genomics is based on 3 months time horizon. Increasing Quantum Genomics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Quantum Genomics SA is useful when determining the fair value of the Quantum stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Quantum Genomics. Since Quantum Genomics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Quantum Stock. However, Quantum Genomics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.12 | Real 0.0987 | Hype 0.12 | Naive 0.12 |
The real value of Quantum Stock, also known as its intrinsic value, is the underlying worth of Quantum Genomics Company, which is reflected in its stock price. It is based on Quantum Genomics' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Quantum Genomics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Quantum Genomics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Quantum Genomics SA helps investors to forecast how Quantum stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Quantum Genomics more accurately as focusing exclusively on Quantum Genomics' fundamentals will not take into account other important factors: Quantum Genomics Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Quantum Genomics's current stock value. Our valuation model uses many indicators to compare Quantum Genomics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Quantum Genomics competition to find correlations between indicators driving Quantum Genomics's intrinsic value. More Info.Quantum Genomics SA is number one stock in price to earning category among related companies. It is number one stock in price to book category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Quantum Genomics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Quantum Genomics' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Quantum Genomics' earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Quantum Genomics' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Quantum Genomics and how it compares across the competition.
About Quantum Genomics Valuation
The stock valuation mechanism determines the current worth of Quantum Genomics SA on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Quantum Genomics SA. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Quantum Genomics based exclusively on its fundamental and basic technical indicators. By analyzing Quantum Genomics's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Quantum Genomics's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Quantum Genomics. We calculate exposure to Quantum Genomics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Quantum Genomics's related companies.Quantum Genomics Socit Anonyme, a biopharmaceutical company, develops drugs to treat cardiovascular diseases. It is also developing QGC011 that is in pre-clinical phase to treat hypertension with combination therapy and QGC006 to optimize the treatment of hypertension with a monotherapy drug. QUANTUM GENOMICS operates under Pharmaceuticals And Biosciences classification in France and is traded on Paris Stock Exchange. It employs 13 people.
8 Steps to conduct Quantum Genomics' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Quantum Genomics' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Quantum Genomics' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Quantum Genomics' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Quantum Genomics' revenue streams: Identify Quantum Genomics' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Quantum Genomics' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Quantum Genomics' growth potential: Evaluate Quantum Genomics' management, business model, and growth potential.
- Determine Quantum Genomics' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Quantum Genomics' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Quantum Genomics SA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Quantum Genomics information on this page should be used as a complementary analysis to other Quantum Genomics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Complementary Tools for Quantum Stock analysis
When running Quantum Genomics' price analysis, check to measure Quantum Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quantum Genomics is operating at the current time. Most of Quantum Genomics' value examination focuses on studying past and present price action to predict the probability of Quantum Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quantum Genomics' price. Additionally, you may evaluate how the addition of Quantum Genomics to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |